Literature DB >> 19726415

Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease.

Joseph Ferrara1, Alan Diamond, Christine Hunter, Anthony Davidson, Michael Almaguer, Joseph Jankovic.   

Abstract

OBJECTIVE: Advanced Parkinson's disease (PD) is associated with various motor and non-motor symptoms which adversely impact health-related quality of life (HRQoL). Subthalamic nucleus (STN) deep brain stimulation (DBS) has been reported to improve some dimensions of HRQoL in appropriately selected candidates. Prior studies of HRQoL following DBS have used instruments comprising a predetermined list of questions which assess issues that are generally relevant in PD, but that may not be of equal or consistent importance to all individuals. In this study, we evaluate the effect of STN DBS on quality of life using the QLS(M), a modular questionnaire in which satisfaction scores for each item are weighted in light of patient-rated importance.
METHODS: We prospectively analysed QLS(M) scores in 21 patients with PD (11 men, mean age 61.5+/-8.6 years) before STN DBS surgery and at a mean 7.4+/-1.5, and again at a mean 16.6+/-6.8 months postoperatively.
RESULTS: Following STN DBS, patients experienced an improvement in HRQoL as measured by various items of the movement disorder and health modules of the QLS(M). Specifically, QLS(M) items pertaining to energy level/enjoyment of life, independence from help, controllability/fluidity of movement and steadiness when standing and walking showed significant improvements, although items concerning general life issues (eg, occupational function, interpersonal relationships, leisure activities) did not improve.
CONCLUSION: Following STN DBS, symptomatic and functional improvements translate into higher HRQoL, with high satisfaction in domains related to movement disorders and general health.

Entities:  

Mesh:

Year:  2009        PMID: 19726415     DOI: 10.1136/jnnp.2009.184127

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation.

Authors:  Amy E Williams; Gladys Marina Arzola; Adriana M Strutt; Richard Simpson; Joseph Jankovic; Michele K York
Journal:  Parkinsonism Relat Disord       Date:  2011-02-11       Impact factor: 4.891

Review 3.  Neuromodulation of cognition in Parkinson's disease.

Authors:  Rachel C Cole; Derrick N Okine; Brooke E Yeager; Nandakumar S Narayanan
Journal:  Prog Brain Res       Date:  2022-02-11       Impact factor: 2.624

4.  Bridging the Gaps in Patient Education for DBS Surgery in Parkinson's Disease.

Authors:  Colleen D Knoop; Robert Kadish; Kathy Hager; Michael C Park; Paul D Loprinzi; Kathrin LaFaver
Journal:  Parkinsons Dis       Date:  2017-08-07

Review 5.  Patient Satisfaction in Surgery for Parkinson's Disease: A Systematic Review of the Literature.

Authors:  Galal A Elsayed; Joshua Y Menendez; Borna E Tabibian; Gustavo Chagoya; Nidal B Omar; Evan Zeiger; Beverly C Walters; Harrison Walker; Barton L Guthrie
Journal:  Cureus       Date:  2019-03-25

6.  Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.

Authors:  Kazuhiro Samura; Yasushi Miyagi; Minako Kawaguchi; Fumiaki Yoshida; Tsuyoshi Okamoto; Masatou Kawashima
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-06-21       Impact factor: 1.742

Review 7.  Challenges in PD Patient Management After DBS: A Pragmatic Review.

Authors:  Malco Rossi; Verónica Bruno; Julieta Arena; Ángel Cammarota; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-02-28

Review 8.  Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Authors:  Sumit Sarkar; James Raymick; Syed Imam
Journal:  Int J Mol Sci       Date:  2016-06-08       Impact factor: 5.923

9.  Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Xiao Dong Liu; Yi Bao; Guang Jian Liu
Journal:  Front Neurol       Date:  2019-08-27       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.